Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × exemestane × Clear all

Sponsor

Conditions

Breast Neoplasms 67 Neoplasm Metastasis 6 Breast Neoplasms, Male 3 Neoplasms 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Skin Diseases 1 Post Menopausal Women With Early Breast Cancer 1 Pain 1 Obesity 1 Metastatic Beast Cancer 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Invasive Early Breast Cancer 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Fatigue 1 Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Breast Carcinoma 1 Advanced Breast Cancer 1

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡